コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 transient increase in the phosphorylation of choline kinase.
2 the predicted amino acid level with the rat choline kinase.
3 efforts selectively targeting P. falciparum choline kinase.
4 esidues are located at the catalytic core of choline kinase.
5 e the mechanism of catalysis by this enzyme, choline kinase A-2 from Caenorhabditis elegans was analy
6 e high degree of structural similarity among choline kinase A-2, aminoglycoside phosphotransferases,
7 ata on the homologous Caenorhabditis elegans choline kinase, a model of the ternary ADP.phosphocholin
8 phosphocholine levels (measured by MRS) and choline kinase activities (r2 = 0.95, P = 0.0008) follow
14 ells was primarily attributable to increased choline kinase activity and increased catabolism mediate
18 inc-depleted cells translated into increased choline kinase activity in vitro and in vivo, and an inc
19 the protein kinase A-mediated stimulation in choline kinase activity involved an increase in the appa
21 ither reaction, an unexpected enhancement of choline kinase activity was observed specifically with t
22 se A resulted in a stimulation (1.9-fold) in choline kinase activity whereas alkaline phosphatase tre
32 n, but rather due to increased expression of choline kinase alpha (CHKA) and an activated deacylation
34 ymes involved in lipid metabolism, including choline kinase alpha (ChoK(alpha)), fatty acid synthase
38 -3-phosphate acyltransferase GPAM along with choline kinase-alpha (CHKA), the enzymes that catabolize
41 7) that inhibited purified recombinant human choline kinase-alpha activity, reduced the steady-state
42 Together, these results further validate choline kinase-alpha as a molecular target for the devel
45 r small molecules that may interact with the choline kinase-alpha substrate binding domain, we identi
47 providing a method to observe the action of choline kinase, an important target for novel cancer the
50 esis pathway combining conserved prokaryotic choline kinase and CTP:phosphocholine cytidylyltransfera
51 dicted to encode a fusion protein containing choline kinase and CTP:phosphocholine cytidylyltransfera
52 A gene was cloned, and recombinant LicCA had choline kinase and CTP:phosphocholine cytidylyltransfera
53 ng a cki1Delta eki1Delta mutant defective in choline kinase and ethanolamine kinase, we examined the
55 s were consistent with the overexpression of choline kinase and phospholipase C detected in the micro
57 lamine was a poor substrate for the purified choline kinase, and it was also poor inhibitor of cholin
58 ined in a protein kinase A sequence motif in choline kinase are target sites for protein kinase A.
60 f thermotolerance, and At1g74320 encodes for choline kinase (AtCK2) that catalyzes the first reaction
63 n is a 1.6-kb intragenic deletion within the choline kinase beta (Chkb) gene, resulting in a complete
65 tation did not affect the phosphorylation of choline kinase by protein kinase A, the S30A (protein ki
66 The Saccharomyces cerevisiae CKI1-encoded choline kinase catalyzes the committed step in phosphati
68 t Saccharomyces cerevisiae, the CKI1-encoded choline kinase catalyzes the committed step in the synth
71 ip between hypoxia, choline metabolites, and choline kinase (Chk) in a human prostate cancer model.
75 oline (trimethyl-2-hydroxyethylammonium) and choline kinase (CK) activity in neoplasms have motivated
76 stoichiometry (0.44 mol of phosphate/mol of choline kinase) consistent with one phosphorylation site
77 The functional importance of RNAi-mediated choline kinase down-regulation on choline phospholipid m
78 choline, other potential substrates for the choline kinase enzyme include ethanolamine, monomethylet
79 eptide maps of the wild type and S30A mutant choline kinase enzymes phosphorylated by protein kinase
82 t small interfering RNA (siRNA) silencing of choline kinase expression in transformed HeLa cells comp
83 se results strongly support the targeting of choline kinase in breast cancer cells with RNAi and show
84 essed normally, but the specific activity of choline kinase in cells expressing the S30A, S85A, and S
85 he purified enzyme and were used to identify choline kinase in insect cells and in S. cerevisiae.
87 erference (RNAi)-mediated down-regulation of choline kinase in nonmalignant and malignant human breas
88 e the existence of separate ethanolamine and choline kinases in mammals and show that ethanolamine ki
90 inase substrate choline (250 microM) and the choline kinase inhibitor hemicholinium-3 (2 mM) enhanced
92 veals a mode of action for two P. falciparum choline kinase inhibitors both in vitro and in vivo.
94 In this work we examined the hypothesis that choline kinase is also phosphorylated by protein kinase
97 The Saccharomyces cerevisiae CKI-encoded choline kinase is phosphorylated on a serine residue and
100 ndent and dependent on the concentrations of choline kinase (K(m) = 27 microg/ml) and ATP (K(m) = 15
101 lted in the derepression of the CKI1-encoded choline kinase (Kennedy pathway enzyme) but decreased th
103 olamine kinase activity of the P. falciparum choline kinase, leading to a severe decrease in the phos
105 nd yeast choline kinases was used to isolate choline kinase-like cDNAs from soybean (Glycine max L.).
106 e N-terminal amino acid sequence of purified choline kinase matched perfectly with the deduced sequen
108 The full-length LicA polypeptide resembles choline kinases of eucaryotes, suggesting that the pathw
109 In vitro, protein kinase A phosphorylated choline kinase on a serine residue with a stoichiometry
110 orted the conclusion that phosphorylation of choline kinase on Ser(30) and Ser(85) by protein kinase
111 owth factor treatment, but the activities of choline kinase or choline-phosphate cytidylyltransferase
115 er(30) and Ser(85), respectively, within the choline kinase protein were substrates for protein kinas
117 e/ethanolamine-binding site of P. falciparum choline kinase, reflecting different types of inhibition
119 ty whereas alkaline phosphatase treatment of choline kinase resulted in a 60% decrease in choline kin
121 58b is a novel anticancer drug that inhibits choline kinase, resulting in inhibition of phosphocholin
122 Hemicholinium-3 (HC-3), an inhibitor of choline kinase, strongly inhibited UV-induced AP-1 activ
123 itogenic Ca2+ effects, cotreatments with the choline kinase substrate choline (250 microM) and the ch
128 subunit molecular mass (73 kDa) of purified choline kinase was in good agreement with the predicted
129 ere were consistent with the conclusion that choline kinase was regulated by protein kinase A phospho
130 yed sequence homology to mammalian and yeast choline kinases was used to isolate choline kinase-like
131 to the Saccharomyces cerevisiae CKI1-encoded choline kinase, which also exhibits ethanolamine kinase
132 ares its regulatory region with heat-induced choline kinase, which has a possible role in heat signal
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。